About vasopharm

Team

Christian Wandersee

Christian Wandersee

Chief Executive Officer

+

Christian Wandersee

Chief Executive Officer

Christian Wandersee is a co-founder. He joined the company in 1999. From January 2000 to July 2004 he served as managing director and CFO. In August 2004 he became CEO of the company.

He graduated with a Master degree in Business Administration from the University of Wuerzburg. Mr. Wandersee started his professional education as an industrial clerk at VARTA Batterie AG, Hanover, Germany. He further spent one year at West Valley College, Saratoga, California, USA.

Frank Tegtmeier, PhD

Frank Tegtmeier, PhD

Chief Scientific Officer

+

Frank Tegtmeier, PhD

Chief Scientific Officer

Dr. Frank Tegtmeier joined vasopharm in 2001.

He worked for more than 5 years in the field of gastroenterology and hepatology at the Oststadt-Hospital Hanover, Germany. Afterwards he acquired 15 years of experience in research & development at Janssen-Cilag, Germany (a Johnson & Johnson company).

As head of the preclinical research of Janssen-Cilag Germany he was in charge of transferring compounds from preclinical CNS-pharmacology to clinical evaluation. 

He was Lecturer at the Heinrich-Heine-University Duesseldorf, Germany and taught Pathophysiology of the mammalian brain. He is author of over 100 publications within the fields of cerebral infarction and cerebral pathophysiology.

Dr Tegtmeier received his PhD from the Hanover Medical School (MHH) and the Institute for Organic Chemistry, Hanover, Germany.

Peter Scheurer, PhD

Peter Scheurer, PhD

Head of CMC
Deputy Quality Manager

+

Peter Scheurer, PhD

Head of CMC
Deputy Quality Manager

Dr. Peter Scheurer joined vasopharm in 2002 from Henkel KGaA, Duesseldorf, where he worked on product optimisation of detergents and adhesives. Dr. Scheurer started at vasopharm as a project leader in drug discovery & development and became the Head of Chemistry, Manufacturing & Control (CMC) in 2006. In December 2017 Dr. Scheurer also assumed the role as Deputy Quality Manager.

Dr. Scheurer received his PhD in chemistry at the University of Siegen, Germany. Before starting his studies, Dr. Scheurer trained as an industrial business management assistant.

Prof Reinhard Schinzel, PhD

Prof Reinhard Schinzel, PhD

Head of Research & Drug Safety Operations

+

Prof Reinhard Schinzel, PhD

Head of Research & Drug Safety Operations

Prof Dr Reinhard Schinzel is Head of Research & Drug Safety Operations and in particular responsible for drug safety and pharmacovigilance in all clinical trials conducted by vasopharm. From 2008 to 2016 he was coordinating the pre-clinical and clinical research and development. From 2002 to 2008 he was also responsible for a diagnostics project, which was out-licensed successfully. He joined vasopharm from the Institute of Physiological Chemistry (University Hospital of Wuerzburg), where he worked for two years as an associate professor focussing in research of glycoxidative stress and degenerative diseases of the kidney and the brain. Prior to that he was an assistant professor and group leader at the same institute with research emphasis in the field of bacterial carbohydrate metabolism and diabetes research.

Dr Schinzel received his PhD in microbiology at/ the University of Wuerzburg, Germany. He gives lectures in biochemistry and cardiovascular biology at the University of Wuerzburg and is author of more than 100 scientific publications, reviews, books and patents. 

Ingrid Pfeuffer, PhD

Ingrid Pfeuffer, PhD

Head of Clinical Operations

+

Ingrid Pfeuffer, PhD

Head of Clinical Operations

Dr. Ingrid Pfeuffer joined vasopharm in 2006 as a freelance consultant for clinical development. Her tasks comprise establishing of monitoring and co-monitoring systems as well as supporting the vasopharm clinical project manager. In the Phase III study she started to serve as Senior Project Manager and assumed the role of Head of Clinical Operations in December 2017.

She was working in clinical research at the phase I/II CRO IKP GmbH, Gruenstadt, Germany for 16 years, and was in charge of the phase II unit, quality assurance and training of CRAs. From 1993 until 2005 she was member of the executive board of IKP GmbH.

Dr. Pfeuffer received her PhD in biology at the Johannes-Gutenberg-University Mainz, Germany.

Claudia Wolf-Werner

Claudia Wolf-Werner

Clinical Trial Manager

+

Claudia Wolf-Werner

Clinical Trial Manager

Claudia Wolf-Werner joined vasopharm in September 2002 and acted as a technical assistant in preclinical R&D until October 2008. From November 2008 to June 2013 she assumed the role of a Clinical Research Associate (CRA) on the VAS203 program, mainly in the field of Co-Monitoring in line with the European multicentre Phase IIa study (NOSTRA trial). She was subsequently appointed CRA & Project Manager for the Phase Ic study in July 2013. In March 2014 Claudia took over the responsibility for Co-Monitoring, and as main contact point of vasopharm for the study sites, the entire management of the sites of the European Phase III (NOSTRA-III) multicentre trial in her current role as Clinical Trial Manager.

She started her professional training in October 1998 at the Professional School for Laboratory Technical Assistants, University of Erlangen, Germany, and spent afterwards one year at the University Clinic of Wuerzburg, Germany (Department of Internal Medicine / Nephrology) before joining vasopharm.

Simone Kirksey

Simone Kirksey

Clinical Trial Assistant

+

Simone Kirksey

Clinical Trial Assistant

Simone Kirksey, joined vasopharm in March 2016 as an Office Manager until she completed her training as Clinical Research Associate (CRA), conducted by the German Chamber of Commerce and Industry, in October 2016. In December 2017, Simone Kirksey assumed in addition the role of authorised person for Archiving.

Upon completion of her professional training as an Art Dealer in 1999, she attended Interpreter's school in Wuerzburg before relocating abroad, where she held civilian positions for the Armed Forces of the United States. After returning to Germany in 2006 she pursued working for the US Military as a contractor until 2014, before enrolling at the University of Applied Science, Munich. After completing her studies in Marketing Management and Business Administration she joined vasopharm.

Rita Gutfreund

Rita Gutfreund

Office Management

+

Rita Gutfreund

Office Management

Rita Gutfreund joined vasopharm as Office Manager in March 2017. Rita is responsible for all office related activities and is backing up vasopharm’s management.

Helge Joa, PhD

Helge Joa, PhD

Quality Manager

+

Helge Joa, PhD

Quality Manager

Dr. Helge Joa joined vasopharm as a Freelance Consultant in March 2017 and acted as a Senior Clinical Research Associate on the VAS203 program, in the field of Co-Monitoring in line with the European multicenter Phase III study (NOSTRA III trial). In December 2017, Dr. Joa joined vasopharm as an employee assuming the role of Quality Manager.

He has been working in clinical research as a CRA since January 2012 on behalf of several sponsors before joining vasopharm.

Dr. Helge Joa received his PhD in the field of molecular biology at the University of Vienna, Austria.

Stefan Dürrnagel, PHD

Stefan Dürrnagel, PHD

Senior Clinical Research Associate

+

Stefan Dürrnagel, PHD

Senior Clinical Research Associate

Dr. Stefan Dürrnagel joined vasopharm as a Freelance Consultant in June 2017 and acts as a Senior Clinical Research Associate. He joined vasopharm as an employee in February 2018. His tasks comprise co-monitoring for the NOSTRA III trial and support of vasopharm’s clinical project management. He gained experience in clinical research as CRA working on several Phase III-IV trials in various clinical indications since 2013.

Dr. Stefan Dürrnagel studied biology at the Universities of Wuerzburg and Mainz and received his PhD in neurobiology at the RWTH Aachen University in 2013. 

Andreas Roth

Andreas Roth

Head of IT Administration

+

Andreas Roth

Head of IT Administration

Andreas Roth joined vasopharm as a Freelance Consultant in April 2006 and acts as an IT Administrator at vasopharm for Server- and Client-Computer, Network periphery, landline and mobile communication.

He is co-founder and managing partner of the company ROTH & TRUNK OHG (established in August 2001) for IT- and Communication-Consulting.